These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 18613837)
21. Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease. Browning JL Immunol Rev; 2008 Jun; 223():202-20. PubMed ID: 18613838 [TBL] [Abstract][Full Text] [Related]
22. T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment. Cheung TC; Oborne LM; Steinberg MW; Macauley MG; Fukuyama S; Sanjo H; D'Souza C; Norris PS; Pfeffer K; Murphy KM; Kronenberg M; Spear PG; Ware CF J Immunol; 2009 Dec; 183(11):7286-96. PubMed ID: 19915044 [TBL] [Abstract][Full Text] [Related]
23. Herpesvirus entry mediator-Ig treatment during immunization aggravates rheumatoid arthritis in the collagen-induced arthritis model. Pierer M; Schulz A; Rossol M; Kendzia E; Kyburz D; Haentzschel H; Baerwald C; Wagner U J Immunol; 2009 Mar; 182(5):3139-45. PubMed ID: 19234211 [TBL] [Abstract][Full Text] [Related]
24. A role for HVEM, but not lymphotoxin-beta receptor, in LIGHT-induced tumor cell death and chemokine production. Pasero C; Barbarat B; Just-Landi S; Bernard A; Aurran-Schleinitz T; Rey J; Eldering E; Truneh A; Costello RT; Olive D Eur J Immunol; 2009 Sep; 39(9):2502-14. PubMed ID: 19701890 [TBL] [Abstract][Full Text] [Related]
25. Immunoregulation by tumor necrosis factor superfamily member LIGHT. Wang Y; Zhu M; Miller M; Fu YX Immunol Rev; 2009 May; 229(1):232-43. PubMed ID: 19426225 [TBL] [Abstract][Full Text] [Related]
26. Molecular basis for herpesvirus entry mediator recognition by the human immune inhibitory receptor CD160 and its relationship to the cosignaling molecules BTLA and LIGHT. Kojima R; Kajikawa M; Shiroishi M; Kuroki K; Maenaka K J Mol Biol; 2011 Nov; 413(4):762-72. PubMed ID: 21959263 [TBL] [Abstract][Full Text] [Related]
27. TNF Superfamily Networks: bidirectional and interference pathways of the herpesvirus entry mediator (TNFSF14). Ware CF; Sedý JR Curr Opin Immunol; 2011 Oct; 23(5):627-31. PubMed ID: 21920726 [TBL] [Abstract][Full Text] [Related]
28. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Sedy JR; Gavrieli M; Potter KG; Hurchla MA; Lindsley RC; Hildner K; Scheu S; Pfeffer K; Ware CF; Murphy TL; Murphy KM Nat Immunol; 2005 Jan; 6(1):90-8. PubMed ID: 15568026 [TBL] [Abstract][Full Text] [Related]
29. HVEM/LIGHT/BTLA/CD160 cosignaling pathways as targets for immune regulation. del Rio ML; Lucas CL; Buhler L; Rayat G; Rodriguez-Barbosa JI J Leukoc Biol; 2010 Feb; 87(2):223-35. PubMed ID: 20007250 [TBL] [Abstract][Full Text] [Related]
30. The HVEM network: new directions in targeting novel costimulatory/co-inhibitory molecules for cancer therapy. Pasero C; Speiser DE; Derré L; Olive D Curr Opin Pharmacol; 2012 Aug; 12(4):478-85. PubMed ID: 22445654 [TBL] [Abstract][Full Text] [Related]
31. Selective blockade of herpesvirus entry mediator-B and T lymphocyte attenuator pathway ameliorates acute graft-versus-host reaction. del Rio ML; Jones ND; Buhler L; Norris P; Shintani Y; Ware CF; Rodriguez-Barbosa JI J Immunol; 2012 May; 188(10):4885-96. PubMed ID: 22490863 [TBL] [Abstract][Full Text] [Related]
32. Lymphtoxin beta receptor-Ig protects from T-cell-mediated liver injury in mice through blocking LIGHT/HVEM signaling. An MM; Fan KX; Cao YB; Shen H; Zhang JD; Lu L; Gao PH; Jiang YY Biol Pharm Bull; 2006 Oct; 29(10):2025-30. PubMed ID: 17015945 [TBL] [Abstract][Full Text] [Related]
33. Slow down and survive: Enigmatic immunoregulation by BTLA and HVEM. Murphy TL; Murphy KM Annu Rev Immunol; 2010; 28():389-411. PubMed ID: 20307212 [TBL] [Abstract][Full Text] [Related]
34. CD8 T cell memory to a viral pathogen requires trans cosignaling between HVEM and BTLA. Flynn R; Hutchinson T; Murphy KM; Ware CF; Croft M; Salek-Ardakani S PLoS One; 2013; 8(10):e77991. PubMed ID: 24205056 [TBL] [Abstract][Full Text] [Related]
35. LIGHT/HVEM/LTβR interaction as a target for the modulation of the allogeneic immune response in transplantation. del Rio ML; Schneider P; Fernandez-Renedo C; Perez-Simon JA; Rodriguez-Barbosa JI Am J Transplant; 2013 Mar; 13(3):541-51. PubMed ID: 23356438 [TBL] [Abstract][Full Text] [Related]
36. Biology and signal transduction pathways of the Lymphotoxin-αβ/LTβR system. Remouchamps C; Boutaffala L; Ganeff C; Dejardin E Cytokine Growth Factor Rev; 2011; 22(5-6):301-10. PubMed ID: 22152226 [TBL] [Abstract][Full Text] [Related]
37. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Mauri DN; Ebner R; Montgomery RI; Kochel KD; Cheung TC; Yu GL; Ruben S; Murphy M; Eisenberg RJ; Cohen GH; Spear PG; Ware CF Immunity; 1998 Jan; 8(1):21-30. PubMed ID: 9462508 [TBL] [Abstract][Full Text] [Related]
38. Regulatory T cell expression of herpesvirus entry mediator suppresses the function of B and T lymphocyte attenuator-positive effector T cells. Tao R; Wang L; Murphy KM; Fraser CC; Hancock WW J Immunol; 2008 May; 180(10):6649-55. PubMed ID: 18453584 [TBL] [Abstract][Full Text] [Related]
39. Lymphtoxin beta receptor-Ig ameliorates TNBS-induced colitis via blocking LIGHT/HVEM signaling. An MM; Fan KX; Zhang JD; Li HJ; Song SC; Liu BG; Gao PH; Zhou Q; Jiang YY Pharmacol Res; 2005 Sep; 52(3):234-44. PubMed ID: 15925518 [TBL] [Abstract][Full Text] [Related]
40. Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis. Scheu S; Alferink J; Pötzel T; Barchet W; Kalinke U; Pfeffer K J Exp Med; 2002 Jun; 195(12):1613-24. PubMed ID: 12070288 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]